Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Dow
Merck
Johnson and Johnson
McKesson

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Dorzolamide Hydrochloride And Timolol Maleate, and when can generic versions of Dorzolamide Hydrochloride And Timolol Maleate launch?

Dorzolamide Hydrochloride And Timolol Maleate is a drug marketed by Akorn Inc, Anda Repository, Aurobindo Pharma Ltd, Bausch And Lomb, Fdc Ltd, Hi Tech Pharma, Lannett Co Inc, Rubicon, Sandoz, Sandoz Inc, Teva Pharms, Watson Labs Inc, and Zambon Spa. and is included in thirteen NDAs.

The generic ingredient in DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE is dorzolamide hydrochloride; timolol maleate. There are fifteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the dorzolamide hydrochloride; timolol maleate profile page.

Summary for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
Drug patent expirations by year for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
Recent Clinical Trials for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of FloridaPhase 1
AllerganPhase 3
AllerganPhase 4

See all DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE clinical trials

Pharmacology for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE

US Patents and Regulatory Information for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn Inc DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 203058-001 Sep 22, 2014 AT RX No No   Start Trial   Start Trial   Start Trial
Lannett Co Inc DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 201998-001 Dec 17, 2014 DISCN No No   Start Trial   Start Trial   Start Trial
Bausch And Lomb DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 090037-001 Jul 14, 2009 AT RX No No   Start Trial   Start Trial   Start Trial
Watson Labs Inc DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 202054-001 Sep 3, 2014 DISCN No No   Start Trial   Start Trial   Start Trial
Rubicon DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 078201-001 Oct 28, 2008 DISCN No No   Start Trial   Start Trial   Start Trial
Anda Repository DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 207523-001 Jun 25, 2019 AT RX No No   Start Trial   Start Trial   Start Trial
Aurobindo Pharma Ltd DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 207630-001 Jul 24, 2018 AT RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
AstraZeneca
Boehringer Ingelheim
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.